.gif)
Concentra Group Holdings Parent, Inc.
83
Recent developments highlight Concentra Group's financial performance and market positioning through earnings reports and industry recognition.
- Concentra Group reported Q2 earnings and revenues surpassing prior benchmarks as of August 6, 2026 [N7].
- The company held a Q1 earnings call with key highlights reported on May 9, 2026 [N8].
- Concentra Group was noted among biotech stocks reaching 52-week highs on October 9, 2026 [N4].
- The company maintains stable risk factors with no material changes reported in the latest 10-Q filing [S2].
Concentra Group Holdings Parent, Inc. is a healthcare company specializing in occupational health centers and onsite health clinics. The company provides services related to workers' compensation, employer services, and consumer health through its network of centers. Its business model focuses on delivering healthcare services primarily to employers and their employees, emphasizing occupational health and wellness.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Concentra Group Holdings Parent, Inc. operates occupational health centers and onsite health clinics. As of September 30, 2026, the company reported $85.82 million in cash and cash equivalents, current assets of $459.66 million, and current liabilities of $352.98 million, yielding a current ratio of 1.3. Net income for the quarter was $65.886 million with EPS of $0.52. Recent news highlights include Q2 earnings and revenues surpassing estimates and the company being noted among biotech stocks at 52-week highs [S2][N7][N4].
Concentra Group's positioning in occupational health and onsite clinics aligns with growing employer demand for workplace health services. The company has demonstrated operational execution with recent earnings and revenue surpassing prior benchmarks. Its liquidity position and profitability metrics as of Q3 2026 indicate financial stability to support ongoing operations and potential expansion.
Risks include potential regulatory changes affecting occupational health services, competitive pressures from other healthcare providers, and economic factors impacting employer healthcare spending. The company's reliance on employer contracts may expose it to client concentration risks. Additionally, any adverse changes in workers' compensation laws or healthcare reimbursement policies could impact financial performance.
The company's moat is derived from its specialized network of occupational health centers and onsite clinics, which cater to employer-based healthcare needs. This specialization creates barriers to entry for competitors due to established relationships with employers and regulatory compliance requirements in occupational health services.
• Regulatory Risk: Changes in healthcare regulations or workers' compensation laws could adversely affect the company's operations and profitability.
• Client Concentration Risk: Dependence on employer contracts may expose the company to risks if key clients reduce or terminate services.
• Competitive Risk: Competition from other healthcare providers and onsite clinic operators could pressure market share and margins.
Business trends: The company continues to focus on occupational health and onsite clinics, with recent earnings and revenue performance indicating operational stability and market recognition.
Execution milestones: Key milestones include quarterly earnings reports surpassing prior benchmarks and maintaining stable risk factors as per SEC filings.
Key risks: Regulatory changes, client concentration, and competitive pressures remain primary risks to business continuity and financial outcomes.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Concentra Group Holdings Parent, Inc. operates in the healthcare sector, specifically providing occupational health centers and onsite health clinics as indicated by SEC filing tags [S1].
- As of September 30, 2026, the company reported cash and cash equivalents of $85.82 million and current assets of $459.66 million, with current liabilities of $352.98 million, resulting in a current ratio of 1.3 and a cash ratio of 0.24 [S2].
- Net income for the quarter ending September 30, 2026, was $65.886 million with basic and diluted earnings per share of $0.52 [S2].
- The company has no material changes in risk factors as per the latest 10-Q filing [S2].
- Recent news highlights include Concentra Group's Q2 earnings and revenues surpassing estimates as of August 6, 2026 [N7].
- The company held a Q1 earnings call with highlights reported on May 9, 2026 [N8].
- Concentra Group was mentioned among biotech stocks at 52-week highs on October 9, 2026 [N4].
Generated 2026-11-06
- S1 | 2026-02-26 | 10-K
- S2 | 2026-11-05 | 10-Q
- N1 | 2026-10-28 | www.nasdaq.com | UHS Misses Q3 Earnings Estimates Despite Higher Patient Volumes | https://www.nasdaq.com/articles/uhs-misses-q3-earnings-estimates-despite-higher-patient-volumes
- N2 | 2026-10-27 | www.nasdaq.com | Centene Q3 Earnings Beat Estimates on Medicare Strength | https://www.nasdaq.com/articles/centene-q3-earnings-beat-estimates-medicare-strength
- N3 | 2026-10-21 | www.nasdaq.com | ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 Outlook | https://www.nasdaq.com/articles/elv-beats-q3-earnings-estimates-carelon-strength-raises-2026-outlook
- N4 | 2026-10-09 | www.nasdaq.com | Biotech Stocks At 52-Week Highs - PCRX +44% On Acquisition News; MANE+14%, HAE+17%, CON, HSTM | https://www.nasdaq.com/articles/biotech-stocks-52-week-highs-pcrx-44-acquisition-news-mane14-hae17-con-hstm
- N5 | 2026-10-08 | www.nasdaq.com | Teladoc Strengthens Solo Platform With New AI-Powered Care Tools | https://www.nasdaq.com/articles/teladoc-strengthens-solo-platform-new-ai-powered-care-tools
- N6 | 2026-10-07 | www.nasdaq.com | Encompass Health Expands Rehab Footprint With New Maine Hospital | https://www.nasdaq.com/articles/encompass-health-expands-rehab-footprint-new-maine-hospital
- N7 | 2026-08-06 | www.nasdaq.com | Concentra Group (CON) Q2 Earnings and Revenues Surpass Estimates | https://www.nasdaq.com/articles/concentra-group-con-q2-earnings-and-revenues-surpass-estimates
- N8 | 2026-05-09 | www.nasdaq.com | Concentra Group Holdings Parent Q1 Earnings Call Highlights | https://www.nasdaq.com/articles/concentra-group-holdings-parent-q1-earnings-call-highlights
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.
Generated by Valye SEC Pipeline Engine